Drug details
Trelegy Ellipta (fluticasone furoate inhalation powder)
type of Respiratory Inhalant Combos, Beta2 Agonists, Corticosteroids, Inhalants, Anticholinergics, Respiratory
Trelegy Ellipta (fluticasone furoate, umeclidinium, and vilanterol inhalation powder), for oral inhalation is used to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis, and/or emphysema.
The drug is often used to treat Chronic obstructive pulmonary disease .
This drug may have the following side effects:
- hives,
- nausea,
- vomiting,
- fever,
- shortness of breath,
- chills,
- tiredness,
- chest pain,
- low blood pressure,
- headache,
- wheezing,
- nervousness,
- weakness,
- cough,
- sore throat,
- increased thirst,
- increased urination,
- fast or irregular heartbeat,
- muscle cramps,
- tremor,
- increased blood pressure,
- eye pain,
- seeing halos around lights,
- tightness in your chest,
- difficulty breathing
- blurry vision,
- white spots on your tongue or cheeks,
- increased trouble breathing,
- increased mucus or change in color of mucus,
- feeling aware of your heartbeat,
- curved spine at the shoulders,
- decreased height,
- changes in posture,
- red eyes,
- skipped or extra heartbeats,
- difficulty or painful urination,
- swelling of the face, throat, and tongue, and
The following drugs are related to Trelegy Ellipta, either as a replacement or used together:
- Duaklir Pressair (aclidinium bromide and formoterol fumarate inhalation powder)
- Albuterol Sulfate Tablets (albuterol sulfate tablets)
- Breztri Aerosphere (budesonide, glycopyrrolate, and formoterol fumarate inhalation aerosol)
- Yupelri (revefenacin inhalation solution)
- Tezspire (tezepelumab-ekko injection, for subcutaneous use)